Source: http://www.wvlegislature.gov/bill_status/bills_text.cfm?billdoc=sb667%20intr.htm&yr=2012&sesstype=RS&billtype=B&houseorig=S&i=667
Timestamp: 2018-03-20 12:24:55
Document Index: 335958629

Matched Legal Cases: ['§60', '§60', '§60', '§60', '§60', '§60']

Introduced Version Senate Bill 667 History
Senate Bill No. 667
(By Senators Stollings, Foster and Jenkins)
[Introduced February 20, 2012; referred to the Committee on Health and Human Resources; and then to the Committee on the Judiciary.]
A BILL to amend and reenact §60A-1-101 of the Code of West Virginia, 1931, as amended; and to amend and reenact §60A-2-204, §60A-2-206, §60A-2-208, §60A-2-210 and §60A-2-212 of said code, all relating generally to schedules of controlled substances; modifying definitions; and updating West Virginia schedules of controlled substances to match federal schedules of controlled substances.
(m) "Drug" means: (1) Substances recognized as drugs in the official "United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States or official National Formulary", or any supplement to any of them; (2) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in man or animals; (3) substances (other than food) intended to affect the structure or any function of the body of man or animals; and (4) substances intended for use as a component of any article specified in clause (1), (2) or (3) of this subdivision. It does not include devices or their components, parts or accessories.
(n) “Immediate derivative” means a substance which the “West Virginia Board of Pharmacy” has found to be and by rule designates as being is the principal compound or any analogue of the parent compound manufactured from a known controlled substance primarily for use and which has equal or similar pharmacologic activity as the parent compound which is necessary to prevent, curtail or limit manufacture.
(6) (7) 4-methoxyamphetamine; some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA;
(7) (8) 5-methyloxy-3, 4-methylenedioxy-amphetamine;
(16) Alpha-methyltryptamine (other name:AMT);
(14) (17) Bufotenine; some trade and other names: 3-(beta-Dimethylaminoethyl)-5-hydroxyindole;3-(2-dimethylaminoethyl) -5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N- dimethyltryptamine; mappine;
(17) (21) Ibogaine; some trade and other names: 7-Ethyl-6, 6 Beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- pyrido [1', 2': 1, 2] azepino [5,4-b] indole; Tabernanthe iboga;
(c) (C) [(6aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol)] {also known as HU-210};
(d)(D) (dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzol[c]chromen-1-ol) {also known as HU-211};
(o) (O) 1-(1-(2-cyclohexylethyl)-(1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone {also known as RCS-8}; and
(H) (I) Ethylmorphine;
(A) 4-anilino-N-phenethyl-4-piperidine (ANPP).
(6) Butalbital;
(4) (8) Chlorhexadol;
(5) (12) Lysergic acid;
(11) (20) Tiletamine and zolazepam or any salt of tiletamine and zolazepam; some trade or other names for a tiletamine-zolazepam combination product: Telazol; some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone; some trade or other names for zolazepam: 4-(2-flurophenyl)-6, 8-dihydro-1, 3, 8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one, flupyrazapon;
(g) (h) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved drug product. (Some other names for dronabinol: (6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b,d] pyran-1- ol or (-)-delta-9-(trans)-tetrahydrocannabinol).
(16) (17) Estazolam;
(23) (25) Halazepam;
(49) (52) Zolpidem;
(7) (8) Pemoline (including organometallic complexes and chelates thereof);
(10) (12) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
(3) Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].
NOTE: The purpose of this bill is to update the schedules of controlled substances in West Virginia code to match the federal schedules of controlled substances. Additionally, the bill makes a technical modification to the definitions of “immediate derivative” and “immediate precursor.”
Strike-throughs indicate language that would be stricken from the present law, and underscoring indicates law that would be added.